$0.2542
0.044120.99%
Last update: Nov 2, 11:26 AM
Acumen Pharmaceuticals Inc (ABOS) Stock Price, Quote, News & History
ABOSNASDAQ
Analysts upgraded MHK and CRWD, downgraded PFSI, cut ABOS’s target, and raised targets for NRXP, REGN and NTSK.
You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.
Other companies in Acumen Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Acumen Pharmaceuticals has a consensus price target of $5.71.
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $0.2542 last updated November 2, 2026 at 11:26 AM EST.
There are no upcoming dividends for Acumen Pharmaceuticals.
Acumen Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Acumen Pharmaceuticals.
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass...
